Aug 2026· Journal of Immunology· Vol 215 8· 0 citations· 217 references
Medicine
TL;DR
The main mechanisms of antigen acquisition, endocytic/lysosomal factors controlling MHCII-restricted processing and presentation, and evidence linking lysosomal dysfunction to autoimmunity are explored.
Abstract
Lysosomes drive antigen proteolysis and peptide loading for major histocompatibility complex class II (MHCII) presentation in antigen-presenting cells (APCs), enabling activation of peptide-specific CD4+ T helper cells (CD4+ Th cells). Tight regulation of endocytic trafficking, protease activity, and peptide editing is required to generate stable peptide-MHCII complexes and balanced immune responses. Conversely, dysregulation of antigen catabolism or loading can promote impaired pathological immunity, including autoimmunity. However, key mechanistic questions remain, including how proteolysis, redox regulation, and peptide editing shape the MHCII ligandome across APC subsets and inflammatory states. In this review, we explore the main mechanisms of antigen acquisition, endocytic/lysosomal factors controlling MHCII-restricted processing and presentation, and evidence linking lysosomal dysfunction to autoimmunity. Understanding the functions of lysosomes in immune cells is crucial for elucidating their roles in physiological and pathological states, for developing targeted therapeutic strategies and for enhancing the safety and efficacy of novel biological entities (NBEs).
This review systematically summarizes the central role of cysteine peptidases in modulating antigen‐presenting cell (APC) function and antitumor immune responses, highlighting their critical significance in overcoming tumor immune evasion. Current research has established that cysteine peptidase subtypes, including c...
This review describes the development of pathway-centered mechanistic synthesis across DNA and RNA virus families and further integrate innate immune antagonism, endoplasmic reticulum stress, antigen-presentation competence, cross-presentation limits, and virus-shaped peptide landscapes into a unified framework for und...
Yu Ye, Ying Zhang, Haobing Nie et al.· FEMS Microbiology Reviews· 0 citations
This work identifies SNX5 as a regulator of MHC class II antigen presentation that influences inflammatory outcomes during pulmonary Mtb infection and identifies SNX5 as a regulator of MHC class II antigen presentation that influences inflammatory outcomes during pulmonary Mtb infection.
Beatriz R. S. Dias, Kubra F. Naqvi, Victoria A. Ektnitphong et al.· Journal of Immunology· 0 citations
This review summarizes how phosphorylation shapes antigen presentation and immune recognition across cancer, infection, and inflammation, and outlines future directions for phosphoantigen-based immunotherapy.
Ramesh Rijal, A. F. Marques· Frontiers in Immunology· 0 citations
It is shown that substantive improvements in cytosolic antigen delivery provided by the fusion-dependent mini-protein ZF5.3 result in concomitant improvements in MHC-I-mediated antigen presentation and B3Z T-cell activation, which could improve the design of peptide vaccines for immunotherapy.
Teresia Chen, Michel DuPage, Alanna Schepartz· bioRxiv· 0 citations
An overview of the PLC as a major determinant of tumor immune escape and a potential therapy target is provided and existing or evolving therapeutic approaches to recover/reprogram PLC functions are explored.
O. Allela, Abdulkareem Shareef, Hayder Naji Sameer et al.· Current Medical Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.